Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
In 2017, liraglutide became the first GLP-1 receptor agonist approved by the FDA to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease, based on results from the LEADER trial
Confirm ketosis with blood ketone testing
Clinicians and pharmacies must stay informed about the supply status of these medications
For a free professional opinion on your case with no obligation, call 1-866-900-7078 now
PubMed laboratory research record [PMID: 18296364] PubMed record related to this compound for laboratory literature review
Curr Opin Pharmacol 7, 398403 (2007)
US$ 27.90
US$ 27.15
US$ 28.68
US$ 26.55
US$ 23.57
